Relationship between recurrent vulvovaginal candidosis and immune mediators in vaginal fluid

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 144, Issue 1, 2009, Pages 59-63

  Weissenbacher, Tobias M ^a   Witkin, Steven S ^c   Gingelmaier, Andrea ^a   Scholz, Christoph ^a   Friese, Klaus ^a,b   Mylonas, Ioannis ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c Department of Obstetrics Gynecology   (United States)

Author keywords

Candida specific IgE; Interleukin 13; Interleukin 4; Interleukin 5; Prostaglandin E 2; Recurrent candidosis; Th1 immune response; Th2 immune response; Total IgE

Indexed keywords

IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; PROSTAGLANDIN E2;

ALLERGIC REACTION; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FUNGAL DETECTION; FUNGUS CULTURE; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECURRENT DISEASE; VAGINA CANDIDIASIS; VAGINA DISCHARGE;

EID: 64149091654     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2009.01.010     Document Type: Article

References (20)

1. Dan M., Kaneti N., Levin D., Poch F., and Samara Z. Vaginitis in a gynecologic practice in Israel: causes and risk factors. Isr Med Assoc J 5 9 (2003) 629-632
2. Linhares L.M., Witkin S.S., Miranda S.D., Fonseca A.M., Pinotti J.A., and Ledger W.J. Differentiation between women with vulvovaginal symptoms who are positive or negative for candida species by culture. Infect Dis Obstet Gynecol 9 4 (2001) 221-225
3. Mardh P.A., Rodrigues A.G., Genc M., Novikova N., Martinez-de-Oliviera J., and Guaschino S. Facts and myths on recurrent vulvovaginal candidosis-a review on epidemiology, clinical manifestations, diagnosis, pathogenesis and therapy. Int J STD AIDS 13 8 (2002) 522-539
4. Barousse M.M., Steele C., Dunlap K., et al. Growth inhibition of Candida albicans by human vaginal epithelia cells. J Infect Dis 184 11 (2001) 1489-1493
5. Maccato M.L., and Kaufman R.H. Fungal vulvovaginitis. Curr Opin Obstet Gynecol 3 6 (1991) 849-852
6. Saporiti A.M., Gomez D., Levalle S., et al. Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use. Rev Argent Microbiol 33 4 (2001) 217-222
7. Sobel J.D. Treatment of vaginal candida infections. Expert Opin Pharmacother 3 8 (2002) 1059-1065
8. Rosedale N., and Browne K. Hyposensitation in the management of recurring vaginal candidiasis. Ann Allergy 43 4 (1979) 250-253
9. Wilton L., Kollarova M., Heeley E., and Shakir S. Relative risk of vaginal candidiasis after use of antibiotics compared with antidepressants in women: postmarketing surveillance data in England. Drug Saf 26 8 (2003) 589-597
10. Comoy E., Pestel J., Stewart G.A., Finkelman F., Capron A., and Thyphronitis G. Do allergens induce type-2 immune responses?. Int Arch Allergy Immunol 118 (1999) 399-402
11. Neves N.A., Carvalho L.P., De Oliveira M.A., et al. Association between atopy and recurrent vaginal candidiasis. Clin Exp Immunol 142 October (1) (2005) 167-171
12. Katsifa H., Tsaparidou S., Diza E., Gil-Lamaignere C., Walsh T.J., and Roilides E. Effects of interleukin-13 on antifungal activity of human monocytes against Candida albicans. FEMS Immunol Med Microbiol 31 October (3) (2001) 211-217
13. Weissenbacher T., Witkin S.S., Ledger W.J., et al. Relationship between clinical diagnosis of recurrent vulvovaginal candidiasis and detection of Candida species by culture and polymerase chain reaction. Arch Gynecol Obstet 279 2 (2009) 125-129
14. Giraldo P., von Nowaskonski A., Gomes F.A., Linhares I., Neves N.A., and Witkin S.S. Vaginal colonization by candida in asymptomatic women with and without a history of recurrent vulvovaginal candidiasis. Obstet Gynecol 95 3 (2000) 413-416
15. Weissenbacher S., Witkin S.S., Tolbert V., et al. Value of Candida polymerase chain reaction and vaginal cytokine analysis for the differential diagnosis of women with recurrent vulvovaginitis. Infect Dis Obstet Gynecol 8 5-6 (2000) 244-247
16. Kosonen J., Rantala A., Little C.H., et al. Increased levels of Candida albicans mannan-specific T-cell-derived antigen binding molecules in patients with invasive candidiasis. Clin Vaccine Immunol 13 4 (2006) 467-475
17. Anton G., Rid J., Mylonas I., Friese K., and Weissenbacher E.R. Evidence of a TH1-shift of local vaginal inflammatory response during bacterial vaginosis. Infection 36 (2008) 147-152
18. Rigg D., Miller M.M., and Metzger W.J. Recurrent vulvovaginitis: treatment with Candida albicans allergen immunotherapy. Am J Obstet Gynecol 162 2 (1990) 332-336
19. Witkin S.S., Jeremias J., and Ledger W.J. A localized vaginal allergic response in women with recurrent vaginitis. J Allergy Clin Immunol 81 2 (1988) 412-416
20. Witkin S.S., Hirsch J., and Ledger W.J. A macrophage defect in women with recurrent candida vaginitis and its reversal in vitro by prostaglandin inhibitors. Am J Obstet Gynecol 155 4 (1986) 790-795